1/201
Looks like no tags are added yet.
Gram positive stain color and why
PURPLE. Thick peptidoglycan holds the crystal violet. Mnemonic from lecture: Gram POSITIVE has more P's (Purple, Peptidoglycan thick)
Gram negative stain color and why
PINK. Thin peptidoglycan layer PLUS an outer membrane made of lipopolysaccharide (LPS); crystal violet washes off
Gram-positive cocci in CLUSTERS
Staphylococcus
Gram-positive cocci in PAIRS/CHAINS
Streptococcus and Enterococcus
Gram-positive RODS
Listeria monocytogenes, Corynebacterium
Gram-positive ANAEROBES
Peptostreptococcus, Cutibacterium, Clostridium spp. (associated with dental infections; can also cause intra-abdominal infections)
Gram-negative COCCI
Neisseria
Gram-negative COCCOBACILLI
Acinetobacter baumannii, Bordetella pertussis, Moraxella catarrhalis
Gram-negative ANAEROBES
Bacteroides fragilis (most clinically important), Prevotella, Fusobacterium
Gram-negative ENTERIC rods (colonize the gut)
Proteus mirabilis, E. coli, Klebsiella, Serratia, Enterobacter cloacae, Citrobacter
Gram-negative rods that do NOT colonize the gut
Pseudomonas aeruginosa, Haemophilus influenzae, Providencia
Where do anaerobes thrive?
Low-oxygen sites: oral cavity, GI tract, deep tissues
Commensal vs pathogen
Commensal = normal flora that isn't necessarily causing infection; pathogen = causes disease. Depends on SITE (E. coli in the gut = normal; E. coli in blood = infection)
Why collect cultures BEFORE starting antibiotics?
Antibiotics can negatively affect culture growth
Stepwise approach to ID (in order)
1) Identify infection type and likely source (community vs healthcare-acquired; anatomical site) 2) Collect cultures FIRST 3) Empiric therapy covering likely pathogens 4) De-escalate based on culture and sensitivity 5) Duration and follow-up (response, toxicity, prophylaxis)
Empiric vs targeted therapy
Empiric = chosen before culture results, based on infection type/likely organisms/patient factors. Targeted = based on culture and susceptibilities
Stewardship: the 4 D's of de-escalation (from lecture)
Right Diagnosis (is there an infection?), Drug, Dose (renally dose!), Duration (shortest effective); then de-escalate: narrow, stop, or switch IV to PO
Why are antibiotics "not benign"?
Adverse effects and C. difficile, increased hospital stay and cost, selective pressure for resistance
Selection pressure
Antibiotics kill susceptible bacteria and leave resistant organisms behind to multiply
Reading a coverage chart: what do +, 0, +/- mean?
+ = generally covers; 0 = does not reliably cover; +/- = variable/partial coverage (NOT reliable). ++ sometimes marks first-line. Coverage does not equal effectiveness at every site (PK/PD and penetration matter)
Antibiogram: what does it show and what's the minimum?
Percent of isolates susceptible to each drug; needs at least 30 isolates to be included
Susceptibility report: what do S, I, SDD, R mean?
S = Susceptible (likely responds at standard dose); I = Intermediate (borderline, may work at high concentrations such as urine); SDD = Susceptible-dose dependent (needs higher-than-standard dosing); R = Resistant (do not use)
MIC
Minimum inhibitory concentration: lowest antibiotic concentration that visibly inhibits bacterial growth in vitro. Compare to breakpoints (set by CLSI). You CANNOT compare MICs between different bug-drug pairs
Susceptibility lab workflow
Culture the sample, identify the organism, determine the MIC, compare the MIC to the breakpoint, report S/I/SDD/R
PK/PD target: Cmax/MIC (concentration-dependent)
Aminoglycosides (higher peak = more killing; large dose with extended interval; low troughs limit toxicity)
PK/PD target: Time > MIC (time-dependent)
Beta-lactams (keep concentration above MIC for most of the interval: more frequent dosing, extended infusion, or continuous infusion)
PK/PD target: AUC/MIC
Vancomycin (has elements of both concentration- and time-dependent killing)
Fluoroquinolone killing pattern
Concentration-dependent (slide 57)
Why give piperacillin/tazobactam as a 4-hour extended infusion?
Beta-lactams exhibit TIME-dependent killing; extended infusion keeps the concentration above the MIC longer
HNPEK
Haemophilus, Neisseria, Proteus, E. coli, Klebsiella (the more common GNs; respiratory + urinary)
SPACE
Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter (nosocomial GNs; more resistant than HNPEK)
Respiratory gram negatives
H. influenzae, Moraxella catarrhalis, Neisseria meningitidis
Urinary gram negatives
E. coli, Klebsiella pneumoniae, Proteus mirabilis
Nosocomial gram negatives
SPACE (Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter)
Which GN group is MORE resistant: HNPEK or SPACE?
SPACE
Staphylococcus: where does it live?
Skin and nares
Coagulase-positive Staph
S. aureus ("infects pretty much everything")
Coagulase-negative Staph (CoNS) examples
S. epidermidis (often a contaminant; forms biofilms on devices); S. saprophyticus (UTIs in young women)
MS vs MR
Methicillin-susceptible vs methicillin-resistant (applies to S. aureus and CoNS)
Staph epidermidis
CoNS; often a contaminant; forms biofilms on devices
Staph saprophyticus
CoNS; causes UTIs in young women
Strep pyogenes
Group A, beta-hemolytic. Pharyngitis, cellulitis, necrotizing fasciitis, rheumatic fever
Strep agalactiae
Group B, beta-hemolytic. Neonatal sepsis, obstetric infections
Strep anginosus
Abscesses
Strep pneumoniae
Meningitis, otitis media, pneumonia, sinusitis
Viridans group strep (mitis, mutans)
Endocarditis after dental procedures
Beta-hemolytic strep are named by...
Groups with letters: Group A (pyogenes) and Group B (agalactiae). Beta-hemolysis = complete lysis of red blood cells on blood agar
Enterococcus: where does it live and what does it cause?
Lives in the GI tract; causes UTI, endocarditis, biliary tree infections
E. faecalis vs E. faecium
faecalis = more common, LESS resistant. faecium = less common, MORE resistant (hospital; often VRE)
VRE
Vancomycin-resistant Enterococcus (usually E. faecium)
Gram-positive group that NO cephalosporin covers
Enterococcus (lecture: NO Enterococcus coverage!!!)
Four mechanisms of antibiotic resistance
Permeability, Enzymes, Binding site changes, Efflux pumps. [extra] Mnemonic: BEEP = Binding site, Enzymes, Efflux, Permeability
Main resistance defense of GRAM POSITIVES
Binding site changes (altered target so the drug no longer fits). GPs have no outer membrane and no periplasmic space
Why do GRAM NEGATIVES have more resistance options?
Two membranes: outer-membrane porins can be altered or deleted (permeability), efflux pumps pump the drug out, and enzymes (beta-lactamases) wait in the periplasmic space (the "moat")
Why can't gram positives harbor beta-lactamases easily?
They have no periplasmic space to hold the enzymes
Intrinsic vs acquired resistance
Intrinsic = built in (e.g., drug too big/bulky to pass GN porins). Acquired = e.g., shared bacterial DNA encoding resistance
Beta-lactamase mechanism
Hydrolyzes the beta-lactam ring, so the antibiotic loses activity. Most common resistance mechanism to beta-lactams
How do we fight beta-lactamases?
Pair the beta-lactam with a beta-lactamase inhibitor (BLI)
Beta-lactamase Class A
Serine: penicillinases, cephalosporinases, ESBLs
Beta-lactamase Class B
Metallo-beta-lactamases: NOT inhibited by any BLIs (cefiderocol is active against MBLs)
Beta-lactamase Class C
AmpC: can be inhibited by next-generation BLIs
Beta-lactamase Class D
OXA-type (includes carbapenemases): can be inhibited by durlobactam
Which class of beta-lactamase is not inhibited by any BLI?
Class B (metallo-beta-lactamases)
AmpC organisms
HECK YES: Hafnia alvei, Enterobacter cloacae, Citrobacter freundii, Klebsiella aerogenes
AmpC: key resistance feature
INDUCIBLE. May look susceptible to 3rd-gen cephalosporins at first, then upregulates AmpC after a few days of therapy and becomes resistant
AmpC drug of choice
Cefepime (stable against AmpC)
ESBL organisms
E. coli, Klebsiella pneumoniae, Proteus mirabilis (all HNPEK members)
ESBL: what does it destroy?
Penicillins, 3rd-generation cephalosporins, monobactams
ESBL drug of choice
Carbapenem
Why is ceftriaxone a bad choice for Enterobacter, Citrobacter, K. aerogenes (HECK YES)?
AmpC is inducible and causes resistance to 3rd-gen cephalosporins. Use cefepime
Why does piperacillin/tazobactam NOT reliably cover Enterobacter/Citrobacter?
AmpC breaks down penicillins and tazobactam is a 1st-gen BLI that is poor at inhibiting AmpC
The S. aureus exception
S. aureus is the major GRAM-POSITIVE that makes beta-lactamase (penicillinase). Most beta-lactamases come from gram negatives
PSSA vs MSSA vs MRSA
PSSA = penicillin-susceptible (no penicillinase). MSSA = makes penicillinase but is susceptible to penicillinase-resistant penicillins (nafcillin, oxacillin). MRSA = has mecA gene, resistant to essentially all beta-lactams
MRSA resistance mechanism
mecA gene codes for PBP2a (altered PBP2), a BINDING SITE change; beta-lactams barely bind it
MSSA resistance mechanism
Penicillinase (an enzyme)
Beta-lactam classes (4)
Penicillins, Cephalosporins, Carbapenems, Monobactam
Beta-lactam mechanism of action
Inhibit bacterial cell wall synthesis by preventing peptidoglycan synthesis
Beta-lactam adverse effects
Hypersensitivity, GI upset, seizures (if drug accumulates, e.g., elderly with poor renal function not renally dosed), cytopenias with prolonged use, interstitial nephritis
Natural penicillins (agents)
Penicillin G (IV), Penicillin G benzathine (IM), Penicillin VK (PO)
Natural penicillin spectrum
Beta strep, Strep anginosus. If susceptible: Strep pneumo, viridans strep, E. faecalis. Covers GP mouth anaerobes. NO gram-negative coverage
Drug of choice for syphilis
Penicillin G benzathine (IM)
[extra] Group A strep pharyngitis: drug class to think of
Natural penicillin (Penicillin VK PO) or amoxicillin, since natural penicillins reliably cover beta-hemolytic strep. (Extends lecture; confirm guideline in rotation)
Aminopenicillins (agents)
Ampicillin (IV), Amoxicillin (PO)
Aminopenicillin spectrum
Beta strep, Strep anginosus, E. faecalis, N. meningitidis. If susceptible: H. flu, E. coli, Proteus
DOC for E. faecalis
Ampicillin (aminopenicillin; 1st line). [extra] Mnemonic: E. faecAlis = Ampicillin
Aminopenicillin + BLI (agents)
Ampicillin/sulbactam (IV), Amoxicillin/clavulanate (PO)
What does adding a BLI to an aminopenicillin add?
Better HNPEK coverage, plus MSSA and anaerobes. Still does NOT cover SPACE
Anti-staphylococcal penicillins (agents)
Nafcillin, oxacillin (IV); dicloxacillin (PO)
Anti-staphylococcal penicillin spectrum
MSSA, MS-CoNS, beta strep, Strep anginosus. NO gram-negative coverage
DOC (1st line) for MSSA and MS-CoNS
Anti-staphylococcal penicillins (nafcillin, oxacillin, dicloxacillin) or 1st-gen cephalosporin (cefazolin)
Piperacillin/tazobactam spectrum
MSSA, MS-CoNS, strep, E. faecalis, HNPEK, Serratia, Pseudomonas, anaerobes. Starts to cover SPACE (Serratia, Pseudomonas) but NOT Enterobacter/Citrobacter (AmpC)
Piperacillin comes only with...
Tazobactam. IV product only
Cephalosporin coverage trend as generation goes up
Gram-positive coverage goes DOWN and gram-negative coverage goes UP (1st gen = best GP; 3rd gen = most GN of the first three). 4th gen is the broadest (adds Pseudomonas and AmpC organisms)
[extra] How the HNPEK GN coverage builds across generations
1st gen = PEK; 2nd gen = H + PEK; 3rd gen (X group) = full HNPEK. Just add letters as the generation goes up
1st-gen cephalosporins (agents)
Cefazolin (IV); cephalexin, cefadroxil (PO)
1st-gen spectrum
MSSA, MS-CoNS, beta strep, Strep anginosus, plus PEK (Proteus, E. coli, Klebsiella)
Cefazolin is 1st line for...
MSSA and MS-CoNS
Targeted therapy example from lecture: susceptible E. coli UTI
Cefazolin (1st gen; covers PEK)
2nd-gen cephalosporins (agents)
Cefuroxime (IV and PO); cephamycins cefotetan and cefoxitin (IV)
2nd-gen spectrum
MSSA, CoNS, strep (a little more strep than 1st gen), H. flu, PEK. Cephamycins ALSO cover anaerobes